VOLUME 61   2000   NUMBER 11

Brainstorms

813 The New Cholinesterase Inhibitors for Alzheimer's Disease, Part 2: Illustrating Their Mechanisms of Action. Stephen M. Stahl
[PDF]

Original Articles

815 Adverse Neuropsychiatric Reactions to Herbal and Over-the-Counter "Antidepressants." Ronald Pies
[Abstract] [PDF]

821 Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression. Arun V. Ravindran, Julien D. Guelfi, Roger M. Lane, and Giovanni B. Cassano
[Abstract] [PDF]

828 Paroxetine Levels in Postpartum Depressed Women, Breast Milk, and Infant Serum. Shaila Misri, John Kim, K. Wayne Riggs, and Xanthoula Kostaras
[Abstract] [PDF]

833 Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine. Bruce J. Kinon, Bruce R. Basson, Julie A. Gilmore, Sandra Malcolm, and Virginia L. Stauffer
[Abstract] [PDF]

841 A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder. Joseph R. Calabrese, Trisha Suppes, Charles L. Bowden, Gary S. Sachs, Alan C. Swann, Susan L. McElroy, Vivek Kusumakar, John A. Ascher, Nancy L. Earl, Paul L. Greene, and Eileen T. Monaghan, for the Lamictal 614 Study Group
[Abstract] [PDF]

851 The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder. Mark E. Schmidt, Maurizio Fava, James M. Robinson, and Rajinder Judge
[Abstract] [PDF]

858 Bupropion SR Reduces Periodic Limb Movements Associated With Arousals From Sleep in Depressed Patients With Periodic Limb Movement Disorder. Eric A. Nofzinger, Amy Fasiczka, Susan Berman, and Michael E. Thase
[Abstract] [PDF]

863 Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder: Changes in Weight With Long-Term Treatment. Maurizio Fava, Rajinder Judge, Sharon L. Hoog, Mary E. Nilsson, and Stephanie C. Koke
[Abstract] [PDF]

868 Schizophrenia-Associated Idiopathic Unconjugated Hyperbilirubinemia (Gilbert's Syndrome). Tsuyoshi Miyaoka, Haruo Seno, Motoi Itoga, Masaaki Iijima, Takuji Inagaki,and Jun Horiguchi
[Abstract] [PDF]

CME Article 879

880 Differences in Quality of Life Domains and Psychopathologic and Psychosocial Factors in Psychiatric Patients. Michael Ritsner, Ilan Modai, Jean Endicott, Olga Rivkin, Yakov Nechamkin, Peretz Barak, Vladimir Goldin, and Alexander Ponizovsky
[Abstract] [PDF]

Letters to the Editor

872 Reboxetine Treatment of Depression in Parkinson's Disease. Matthias R. Lemke
[PDF]

872 Olanzapine-Induced Neutropenia in Patients With History of Clozapine Treatment: Two Case Reports From a State Psychiatric Institution. Christian J. Teter, John J. Early, and Richard J. Frachtling
[PDF]

873 Venlafaxine Versus Sertraline for Major Depressive Disorder. Thomas N. Wise and Michael J. Sheridan
[PDF]

874 Adverse Events of Fluoxetine: Postmarketing Compared With Premarketing Clinical Trials. Mahmoud N. Musa and James M. Staneluis
[PDF]

874 Diagnosing Melancholia. Iwona Chelminski, Mark Zimmerman, and Jill I. Mattia
[PDF]

Book reviews 876

Information for Authors

see July 2000, pages 542544 or our Web site at www.psychiatrist.com/author.htm